Cilais consolidated its position as a leader in the market of erectile dysfunction treatment

According to IMS data, it was identified that prescription cost of Cialis in the first quarter of 2014 was 6.31 billion won. It maintained erectile dysfunction drug market share of 26.2% in the first quarter of this year following 26.7% in the fourth quarter of last year, consolidating its position as a leader. It showed a gap of more than 8% between second place treatment despite strong offens...